Sensei Biotherapeutics, Inc. (SNSE)

Sensei Biotherapeutics Statistics

Total Valuation

SNSE has a market cap or net worth of $13.19 million. The enterprise value is -$12.88 million.

Market Cap	13.19M
Enterprise Value	-12.88M

Important Dates

The next estimated earnings date is Thursday, November 13, 2025, before market open.

Earnings Date	Nov 13, 2025
Ex-Dividend Date	n/a

Share Statistics

SNSE has 1.26 million shares outstanding. The number of shares has increased by 0.14% in one year.

Current Share Class	1.26M
Shares Outstanding	1.26M
Shares Change (YoY)	+0.14%
Shares Change (QoQ)	+0.10%
Owned by Insiders (%)	2.30%
Owned by Institutions (%)	6.18%
Float	828,299

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.48
P/TBV Ratio	0.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.64, with a Debt / Equity ratio of 0.09.

Current Ratio	7.64
Quick Ratio	7.39
Debt / Equity	0.09
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-441.41

Financial Efficiency

Return on equity (ROE) is -67.47% and return on invested capital (ROIC) is -38.64%.

Return on Equity (ROE)	-67.47%
Return on Assets (ROA)	-36.75%
Return on Invested Capital (ROIC)	-38.64%
Return on Capital Employed (ROCE)	-96.47%
Revenue Per Employee	n/a
Profits Per Employee	-$1.79M
Employee Count	15
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -15.89% in the last 52 weeks. The beta is 0.31, so SNSE's price volatility has been lower than the market average.

Beta (5Y)	0.31
52-Week Price Change	-15.89%
50-Day Moving Average	9.54
200-Day Moving Average	8.55
Relative Strength Index (RSI)	48.42
Average Volume (20 Days)	62,781

Short Selling Information

The latest short interest is 9,467, so 0.75% of the outstanding shares have been sold short.

Short Interest	9,467
Short Previous Month	10,390
Short % of Shares Out	0.75%
Short % of Float	1.14%
Short Ratio (days to cover)	2.42

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-26.93M
Pretax Income	-26.82M
Net Income	-26.82M
EBITDA	-26.19M
EBIT	-26.93M
Earnings Per Share (EPS)	-$21.30

Balance Sheet

The company has $28.63 million in cash and $2.56 million in debt, giving a net cash position of $26.07 million or $20.67 per share.

Cash & Cash Equivalents	28.63M
Total Debt	2.56M
Net Cash	26.07M
Net Cash Per Share	$20.67
Equity (Book Value)	27.31M
Book Value Per Share	21.66
Working Capital	25.70M

Cash Flow

In the last 12 months, operating cash flow was -$24.27 million and capital expenditures -$16,000, giving a free cash flow of -$24.28 million.

Operating Cash Flow	-24.27M
Capital Expenditures	-16,000
Free Cash Flow	-24.28M
FCF Per Share	-$19.25

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SNSE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.14%
Shareholder Yield	-0.14%
Earnings Yield	-203.31%
FCF Yield	-184.04%

Analyst Forecast

The average price target for SNSE is $72.50, which is 593.12% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$72.50
Price Target Difference	593.12%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-12.76%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 17, 2025. It was a reverse split with a ratio of 1:20.

Last Split Date	Jun 17, 2025
Split Type	Reverse
Split Ratio	1:20

Scores

Altman Z-Score	n/a
Piotroski F-Score	1